Since this active sequence resides within the cancer-associated alternative splicing domain—fibronectin type III repeat A2 (FNIII-A2)–of the TNC molecule [14], it is presumed that the β1-integrin activation induced by TNIIIA2-containing TNC peptides/fragments may contribute to the pathogenesis of cancer. This evidence concerns the gene TNC and cancer.